(Q44960569)

7 December 2017

title

Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease (English)

1 reference

7 December 2017

1

1 reference

7 December 2017

D P Mikhailidis

2

1 reference

7 December 2017

A A Papageorgiou

3

1 reference

7 December 2017

V I Bouloukos

4

1 reference

7 December 2017

A N Pehlivanidis

5

1 reference

7 December 2017

A N Symeonidis

6

1 reference

7 December 2017

M Elisaf

7

1 reference

7 December 2017

GREACE Study Collaborative Group

8

1 reference

7 December 2017

publication date

1 November 2004

1 reference

Journal of Human Hypertension

7 December 2017

published in

1 reference

7 December 2017

volume

18

1 reference

7 December 2017

issue

11

1 reference

7 December 2017

page(s)

781-788

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Statins and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

The Effects of Lipid-Regulating Therapy on Haemostatic Parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Early vascular benefits of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

The effects of antihypertensive therapy on haemostatic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Effect of quinapril or metoprolol on circadian sympathetic and parasympathetic modulation after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Coronary imaging: angiography shows the stenosis, but IVUS, CT, and MRI show the plaque.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Endothelium-dependent responses in patients with hypercholesterolemic coronary artery disease under the effects of simvastatin and enalapril, either separately or combined

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Comparison of endothelial pleiotropic actions of angiotensin converting enzyme inhibitors and statins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Heart rate variability as a means of assessing prognosis after acute myocardial infarction. A 3-year follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Depressed heart rate variability is associated with events in patients with stable coronary artery disease and preserved left ventricular function. REGRESS Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Aortic stiffness as a risk factor for recurrent acute coronary events in patients with ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001748

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001748

1 reference

Dimensions Publication ID

7 December 2017

1042099873

0 references

1 reference